Sign in
Taking peopleNo phase

Effects of Primary Physician Presence in AI-Synthesized SGLT2 Inhibitor Educational Videos for Heart Failure

Key facts

Who runs it
Keimyung University Dongsan Medical Center
Where
South Korea1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
150 people, planned
Started
21 Aug 2026
Expected to end
31 Jul 2027
Type of study
Interventional, 4 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • SGLT2 Inhibitor Educational Video
Record updated
16 November 2026

Who can take part

Age
19 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Adults aged 19 years or older
  • Patients diagnosed with heart failure or those visiting the cardiology outpatient clinic with suspected heart failure symptoms (e.g., dyspnea, edema)
  • Patients currently taking or scheduled to be prescribed SGLT2 inhibitors for the treatment of heart failure
  • Patients who are able to watch the educational video during the outpatient waiting time and complete the survey after the consultation
  • Patients who fully understand the purpose and procedures of this study and voluntarily provide written informed consent

Who cannot take part

  • Patients with expected acute exacerbation of heart failure or a life expectancy of 1 year or less
  • Patients scheduled for heart failure-related surgery or procedures
  • Patients who are currently participating in, or have participated in within the past 6 months, another intervention study related to heart failure education
  • Patients who do not understand the contents of this study or do not consent to the study due to cognitive decline, etc
  • Patients who have difficulty watching the video due to visual or hearing impairments
  • Other patients deemed inappropriate for study participation by the investigator

This trial is currently available in South Korea.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The purpose of this study is to evaluate the effect of the primary attending physician's presence in educational videos on patient satisfaction and educational effectiveness.

The 4 groups in the trial

  • Doctor A - Attending Physician VideoTreatment being tested

    Participants watch an AI-generated educational video during outpatient waiting time, in which Doctor A is presented as their primary physician.

    Treatment: SGLT2 Inhibitor Educational Video

  • Doctor A - Non-Attending Physician VideoExisting treatment, for comparison

    Participants watch an AI-generated educational video during outpatient waiting time, in which Doctor A is presented as a general cardiologist (non-attending).

    Treatment: SGLT2 Inhibitor Educational Video

  • Doctor B - Attending Physician VideoTreatment being tested

    Participants watch an AI-generated educational video during outpatient waiting time, in which Doctor B is presented as their primary physician.

    Treatment: SGLT2 Inhibitor Educational Video

  • Doctor B - Non-Attending Physician VideoExisting treatment, for comparison

    Participants watch an AI-generated educational video during outpatient waiting time, in which Doctor B is presented as a general cardiologist (non-attending).

    Treatment: SGLT2 Inhibitor Educational Video

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effects of Primary Physician Presence in SGLT2 Inhibitor-Focused Heart Failure Educational Videos During Outpatient Waiting Time on Patient Satisfaction and Educational Effectiveness : A Randomized 2x2 Factorial Study
Record updated
16 November 2026